世界の皮膚ガン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Skin Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5271 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、皮膚ガンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞がん、扁平上皮がん、黒色腫、その他）、用途別市場規模（病院・診療所、診断センター、がん研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚ガンの市場動向 ・企業の競争状況、市場シェア ・皮膚ガンの種類別市場規模（細胞がん、扁平上皮がん、黒色腫、その他） ・皮膚ガンの用途別市場規模（病院・診療所、診断センター、がん研究所） ・皮膚ガンの北米市場規模2016-2027（アメリカ、カナダ） ・皮膚ガンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚ガンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚ガンの中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚ガンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Novartis、Sun Pharma、Elekta、Varian Medical Systems、Cannabis Science、Cellceutix、LEO Pharma、Moberg Pharma、Mylan、Eli Lilly、Bristol Myers Squibb、Boehringer Ingelheim、Aqua Pharmaceuticals、Bausch Health、Merck） ・結論

Skin cancer is the most common type of cancer, which arise due to uncontrolled growth of abnormal skin cells. It occurs when skin cells are damaged by unrepaired DNA or genetic defects that lead the uncontrolled growth of cells in the skin.

Market Analysis and Insights: Global Skin Cancer Market
The global Skin Cancer market size is projected to reach US$ 692.4 million by 2026, from US$ 491.1 million in 2019, at a CAGR of 5.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Cancer market.

Global Skin Cancer Scope and Market Size
Skin Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cell carcinoma
Squamous-cell Carcinoma
Melanoma
Others

Segment by Application
Hospital and Clinics
Diagnostic Centers
Cancer Research Institute

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Novartis
Sun Pharma
Elekta
Varian Medical Systems
Cannabis Science
Cellceutix
LEO Pharma
Moberg Pharma
Elekta
Varian Medical Systems
Bristol Myers Squibb
Boehringer Ingelheim
Aqua Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell carcinoma
1.2.3 Squamous-cell Carcinoma
1.2.4 Melanoma
1.2.5 Others
1.3 Market by Application
1.3.1 Global Skin Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital and Clinics
1.3.3 Diagnostic Centers
1.3.4 Cancer Research Institute
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Skin Cancer Market Perspective (2016-2027)
2.2 Skin Cancer Growth Trends by Regions
2.2.1 Skin Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Skin Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Skin Cancer Industry Dynamic
2.3.1 Skin Cancer Market Trends
2.3.2 Skin Cancer Market Drivers
2.3.3 Skin Cancer Market Challenges
2.3.4 Skin Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Players by Revenue
3.1.1 Global Top Skin Cancer Players by Revenue (2016-2021)
3.1.2 Global Skin Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Skin Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin Cancer Revenue
3.4 Global Skin Cancer Market Concentration Ratio
3.4.1 Global Skin Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Cancer Revenue in 2020
3.5 Skin Cancer Key Players Head office and Area Served
3.6 Key Players Skin Cancer Product Solution and Service
3.7 Date of Enter into Skin Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Skin Cancer Breakdown Data by Type
4.1 Global Skin Cancer Historic Market Size by Type (2016-2021)
4.2 Global Skin Cancer Forecasted Market Size by Type (2022-2027)

5 Skin Cancer Breakdown Data by Application
5.1 Global Skin Cancer Historic Market Size by Application (2016-2021)
5.2 Global Skin Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Skin Cancer Market Size (2016-2027)
6.2 North America Skin Cancer Market Size by Type
6.2.1 North America Skin Cancer Market Size by Type (2016-2021)
6.2.2 North America Skin Cancer Market Size by Type (2022-2027)
6.2.3 North America Skin Cancer Market Size by Type (2016-2027)
6.3 North America Skin Cancer Market Size by Application
6.3.1 North America Skin Cancer Market Size by Application (2016-2021)
6.3.2 North America Skin Cancer Market Size by Application (2022-2027)
6.3.3 North America Skin Cancer Market Size by Application (2016-2027)
6.4 North America Skin Cancer Market Size by Country
6.4.1 North America Skin Cancer Market Size by Country (2016-2021)
6.4.2 North America Skin Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Skin Cancer Market Size (2016-2027)
7.2 Europe Skin Cancer Market Size by Type
7.2.1 Europe Skin Cancer Market Size by Type (2016-2021)
7.2.2 Europe Skin Cancer Market Size by Type (2022-2027)
7.2.3 Europe Skin Cancer Market Size by Type (2016-2027)
7.3 Europe Skin Cancer Market Size by Application
7.3.1 Europe Skin Cancer Market Size by Application (2016-2021)
7.3.2 Europe Skin Cancer Market Size by Application (2022-2027)
7.3.3 Europe Skin Cancer Market Size by Application (2016-2027)
7.4 Europe Skin Cancer Market Size by Country
7.4.1 Europe Skin Cancer Market Size by Country (2016-2021)
7.4.2 Europe Skin Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Skin Cancer Market Size (2016-2027)
8.2 Asia-Pacific Skin Cancer Market Size by Type
8.2.1 Asia-Pacific Skin Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin Cancer Market Size by Application
8.3.1 Asia-Pacific Skin Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin Cancer Market Size by Region
8.4.1 Asia-Pacific Skin Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Skin Cancer Market Size (2016-2027)
9.2 Latin America Skin Cancer Market Size by Type
9.2.1 Latin America Skin Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Skin Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Skin Cancer Market Size by Type (2016-2027)
9.3 Latin America Skin Cancer Market Size by Application
9.3.1 Latin America Skin Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Skin Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Skin Cancer Market Size by Application (2016-2027)
9.4 Latin America Skin Cancer Market Size by Country
9.4.1 Latin America Skin Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Skin Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Skin Cancer Market Size (2016-2027)
10.2 Middle East & Africa Skin Cancer Market Size by Type
10.2.1 Middle East & Africa Skin Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin Cancer Market Size by Application
10.3.1 Middle East & Africa Skin Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin Cancer Market Size by Country
10.4.1 Middle East & Africa Skin Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Skin Cancer Introduction
11.1.4 Roche Revenue in Skin Cancer Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Skin Cancer Introduction
11.2.4 Novartis Revenue in Skin Cancer Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Sun Pharma
11.3.1 Sun Pharma Company Details
11.3.2 Sun Pharma Business Overview
11.3.3 Sun Pharma Skin Cancer Introduction
11.3.4 Sun Pharma Revenue in Skin Cancer Business (2016-2021)
11.3.5 Sun Pharma Recent Development
11.4 Elekta
11.4.1 Elekta Company Details
11.4.2 Elekta Business Overview
11.4.3 Elekta Skin Cancer Introduction
11.4.4 Elekta Revenue in Skin Cancer Business (2016-2021)
11.4.5 Elekta Recent Development
11.5 Varian Medical Systems
11.5.1 Varian Medical Systems Company Details
11.5.2 Varian Medical Systems Business Overview
11.5.3 Varian Medical Systems Skin Cancer Introduction
11.5.4 Varian Medical Systems Revenue in Skin Cancer Business (2016-2021)
11.5.5 Varian Medical Systems Recent Development
11.6 Cannabis Science
11.6.1 Cannabis Science Company Details
11.6.2 Cannabis Science Business Overview
11.6.3 Cannabis Science Skin Cancer Introduction
11.6.4 Cannabis Science Revenue in Skin Cancer Business (2016-2021)
11.6.5 Cannabis Science Recent Development
11.7 Cellceutix
11.7.1 Cellceutix Company Details
11.7.2 Cellceutix Business Overview
11.7.3 Cellceutix Skin Cancer Introduction
11.7.4 Cellceutix Revenue in Skin Cancer Business (2016-2021)
11.7.5 Cellceutix Recent Development
11.8 LEO Pharma
11.8.1 LEO Pharma Company Details
11.8.2 LEO Pharma Business Overview
11.8.3 LEO Pharma Skin Cancer Introduction
11.8.4 LEO Pharma Revenue in Skin Cancer Business (2016-2021)
11.8.5 LEO Pharma Recent Development
11.9 Moberg Pharma
11.9.1 Moberg Pharma Company Details
11.9.2 Moberg Pharma Business Overview
11.9.3 Moberg Pharma Skin Cancer Introduction
11.9.4 Moberg Pharma Revenue in Skin Cancer Business (2016-2021)
11.9.5 Moberg Pharma Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Skin Cancer Introduction
11.10.4 Mylan Revenue in Skin Cancer Business (2016-2021)
11.10.5 Mylan Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Skin Cancer Introduction
11.11.4 Eli Lilly Revenue in Skin Cancer Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 Bristol Myers Squibb
11.12.1 Bristol Myers Squibb Company Details
11.12.2 Bristol Myers Squibb Business Overview
11.12.3 Bristol Myers Squibb Skin Cancer Introduction
11.12.4 Bristol Myers Squibb Revenue in Skin Cancer Business (2016-2021)
11.12.5 Bristol Myers Squibb Recent Development
11.13 Boehringer Ingelheim
11.13.1 Boehringer Ingelheim Company Details
11.13.2 Boehringer Ingelheim Business Overview
11.13.3 Boehringer Ingelheim Skin Cancer Introduction
11.13.4 Boehringer Ingelheim Revenue in Skin Cancer Business (2016-2021)
11.13.5 Boehringer Ingelheim Recent Development
11.14 Aqua Pharmaceuticals
11.14.1 Aqua Pharmaceuticals Company Details
11.14.2 Aqua Pharmaceuticals Business Overview
11.14.3 Aqua Pharmaceuticals Skin Cancer Introduction
11.14.4 Aqua Pharmaceuticals Revenue in Skin Cancer Business (2016-2021)
11.14.5 Aqua Pharmaceuticals Recent Development
11.15 Bausch Health
11.15.1 Bausch Health Company Details
11.15.2 Bausch Health Business Overview
11.15.3 Bausch Health Skin Cancer Introduction
11.15.4 Bausch Health Revenue in Skin Cancer Business (2016-2021)
11.15.5 Bausch Health Recent Development
11.16 Merck
11.16.1 Merck Company Details
11.16.2 Merck Business Overview
11.16.3 Merck Skin Cancer Introduction
11.16.4 Merck Revenue in Skin Cancer Business (2016-2021)
11.16.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Skin Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell carcinoma
Table 3. Key Players of Squamous-cell Carcinoma
Table 4. Key Players of Melanoma
Table 5. Key Players of Others
Table 6. Global Skin Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Skin Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Skin Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Skin Cancer Market Share by Regions (2016-2021)
Table 10. Global Skin Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Skin Cancer Market Share by Regions (2022-2027)
Table 12. Skin Cancer Market Trends
Table 13. Skin Cancer Market Drivers
Table 14. Skin Cancer Market Challenges
Table 15. Skin Cancer Market Restraints
Table 16. Global Skin Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Skin Cancer Market Share by Players (2016-2021)
Table 18. Global Top Skin Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer as of 2020)
Table 19. Ranking of Global Top Skin Cancer Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Skin Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Skin Cancer Product Solution and Service
Table 23. Date of Enter into Skin Cancer Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Skin Cancer Revenue Market Share by Type (2016-2021)
Table 27. Global Skin Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Skin Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Skin Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Skin Cancer Revenue Market Share by Application (2016-2021)
Table 31. Global Skin Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Skin Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Skin Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Skin Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Skin Cancer Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Skin Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Skin Cancer Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Skin Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Skin Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Skin Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Skin Cancer Product
Table 66. Roche Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Skin Cancer Product
Table 71. Novartis Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Sun Pharma Company Details
Table 74. Sun Pharma Business Overview
Table 75. Sun Pharma Skin Cancer Product
Table 76. Sun Pharma Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 77. Sun Pharma Recent Development
Table 78. Elekta Company Details
Table 79. Elekta Business Overview
Table 80. Elekta Skin Cancer Product
Table 81. Elekta Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 82. Elekta Recent Development
Table 83. Varian Medical Systems Company Details
Table 84. Varian Medical Systems Business Overview
Table 85. Varian Medical Systems Skin Cancer Product
Table 86. Varian Medical Systems Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 87. Varian Medical Systems Recent Development
Table 88. Cannabis Science Company Details
Table 89. Cannabis Science Business Overview
Table 90. Cannabis Science Skin Cancer Product
Table 91. Cannabis Science Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 92. Cannabis Science Recent Development
Table 93. Cellceutix Company Details
Table 94. Cellceutix Business Overview
Table 95. Cellceutix Skin Cancer Product
Table 96. Cellceutix Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 97. Cellceutix Recent Development
Table 98. LEO Pharma Company Details
Table 99. LEO Pharma Business Overview
Table 100. LEO Pharma Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 101. LEO Pharma Recent Development
Table 102. Moberg Pharma Company Details
Table 103. Moberg Pharma Business Overview
Table 104. Moberg Pharma Skin Cancer Product
Table 105. Moberg Pharma Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 106. Moberg Pharma Recent Development
Table 107. Mylan Company Details
Table 108. Mylan Business Overview
Table 109. Mylan Skin Cancer Product
Table 110. Mylan Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 111. Mylan Recent Development
Table 112. Eli Lilly Company Details
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Skin Cancer Product
Table 115. Eli Lilly Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 116. Eli Lilly Recent Development
Table 117. Bristol Myers Squibb Company Details
Table 118. Bristol Myers Squibb Business Overview
Table 119. Bristol Myers Squibb Skin Cancer Product
Table 120. Bristol Myers Squibb Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 121. Bristol Myers Squibb Recent Development
Table 122. Boehringer Ingelheim Company Details
Table 123. Boehringer Ingelheim Business Overview
Table 124. Boehringer Ingelheim Skin Cancer Product
Table 125. Boehringer Ingelheim Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 126. Boehringer Ingelheim Recent Development
Table 127. Aqua Pharmaceuticals Company Details
Table 128. Aqua Pharmaceuticals Business Overview
Table 129. Aqua Pharmaceuticals Skin Cancer Product
Table 130. Aqua Pharmaceuticals Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 131. Aqua Pharmaceuticals Recent Development
Table 132. Bausch Health Company Details
Table 133. Bausch Health Business Overview
Table 134. Bausch Health Skin Cancer Product
Table 135. Bausch Health Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 136. Bausch Health Recent Development
Table 137. Merck Company Details
Table 138. Merck Business Overview
Table 139. Merck Skin Cancer Product
Table 140. Merck Revenue in Skin Cancer Business (2016-2021) & (US$ Million)
Table 141. Merck Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Cancer Market Share by Type: 2020 VS 2027
Figure 2. Cell carcinoma Features
Figure 3. Squamous-cell Carcinoma Features
Figure 4. Melanoma Features
Figure 5. Others Features
Figure 6. Global Skin Cancer Market Share by Application: 2020 VS 2027
Figure 7. Hospital and Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Cancer Research Institute Case Studies
Figure 10. Skin Cancer Report Years Considered
Figure 11. Global Skin Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Skin Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Skin Cancer Market Share by Regions: 2020 VS 2027
Figure 14. Global Skin Cancer Market Share by Regions (2022-2027)
Figure 15. Global Skin Cancer Market Share by Players in 2020
Figure 16. Global Top Skin Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Skin Cancer Revenue in 2020
Figure 18. Global Skin Cancer Revenue Market Share by Type (2016-2021)
Figure 19. Global Skin Cancer Revenue Market Share by Type (2022-2027)
Figure 20. North America Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Skin Cancer Market Share by Type (2016-2027)
Figure 22. North America Skin Cancer Market Share by Application (2016-2027)
Figure 23. North America Skin Cancer Market Share by Country (2016-2027)
Figure 24. United States Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Skin Cancer Market Share by Type (2016-2027)
Figure 28. Europe Skin Cancer Market Share by Application (2016-2027)
Figure 29. Europe Skin Cancer Market Share by Country (2016-2027)
Figure 30. Germany Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Skin Cancer Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Skin Cancer Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Skin Cancer Market Share by Region (2016-2027)
Figure 40. China Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Skin Cancer Market Share by Type (2016-2027)
Figure 48. Latin America Skin Cancer Market Share by Application (2016-2027)
Figure 49. Latin America Skin Cancer Market Share by Country (2016-2027)
Figure 50. Mexico Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Skin Cancer Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Skin Cancer Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Skin Cancer Market Share by Country (2016-2027)
Figure 56. Turkey Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Skin Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 61. Sun Pharma Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 62. Elekta Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 63. Varian Medical Systems Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 64. Cannabis Science Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 65. Cellceutix Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 66. LEO Pharma Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 67. Moberg Pharma Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 70. Bristol Myers Squibb Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 71. Boehringer Ingelheim Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 72. Aqua Pharmaceuticals Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 73. Bausch Health Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Skin Cancer Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---